CD36 and lung cancer: In lung cancer, increased methylation of CD36 promotes cancer progression, whereas decitabine and chidamide synergistically inhibit the growth of lung tumor; these findings indicate that CD36 demethylation might represent a potential strategy for tumor therapy 57.